- Posted by: Dr Rivera
FDA approves new medication for osteoarthritis pain
FDA approval of Zorvolex was based on a double-blind placebo-controlled study which enrolled
- Posted by: Dr Rivera
FDA approves Otezla for psoriatic arthritis
The U.S. Food and Drug Administration approved Otezla (apremilast) to treat adults with active
- Posted by: Dr Rivera
Immunossuppressive therapy during pregnancy maybe safe to fetus
Women with chronic autoimmune diseases who take immunosuppressive medications during their
- Posted by: Dr Rivera
Recommendations on calcium intake
In an assessment of the scientific literature, reported as a perspective piece today in the New
- Posted by: Dr Rivera
Updated systemic sclerosis criteria may help in early diagnosis
New classification criteria for systemic sclerosis have just been published and are more
- Posted by: Dr Rivera
Fish Oil May Benefit Patients With Early RA
Research published online in Annals of the Rheumatic Diseases suggests that “high-dose fish oil
- Posted by: Dr Rivera
New Injectable for Psoriatic Arthritis Approved by the FDA
The US Food and Drug Administration approved Antares Pharma Inc.’s (ATRS) injectable Otrexup,
- Posted by: Dr Rivera
Ustekinumab Approved for Psoriatic Arthritis
The FDA has approved ustekinumab (Stelara) alone or in combination with methotrexate for adults
- Posted by: Dr Rivera
New Safety Measures
The FDA’s new guidance for extended-release/long-acting opiods will likely impact the use
- Posted by: Dr Rivera
New Safety Measures Announced for Extended-release and Long-acting Opiods
The FDA’s new guidance for extended-release/long-acting opiods will likely impact the use